Home › Funds › Encore Global Management, LP › CRSP

Encore Global Management, LP position in CRSP

CRISPR THERAPEUTICS AG · Health Care

Encore Global Management, LP reported holding 30,557 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 1.86% of its reported portfolio and ranking #27 among its reported holdings. Encore Global Management, LP has disclosed CRSP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)30.56K sh
Reported value held$1.69M
Portfolio Weight1.86%
First reportedQ2 2026
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Encore Global Management, LP's CRSP position evolved

Encore Global Management, LP first disclosed a stake in CRSP in Q2 2026 at 30,557 shares (US$1.7M). The position peaked in Q3 2026 at 30,557 shares, worth US$1.7M. Across 2 filings, Encore Global Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 30,557 shares valued at US$1.7M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 30.56K $1.67M New
Q3 2026 30.56K $1.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRSP and 13F data

CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 31 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRSP

All CRSP fund holders →

FAQ

How long has Encore Global Management, LP held CRSP?

Encore Global Management, LP has disclosed CRSP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Encore Global Management, LP's current position in CRSP?

As of Q3 2026, Encore Global Management, LP holds 30.56K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $1.69M, representing 1.86% of its reported portfolio and ranking #27.

Has Encore Global Management, LP been buying or selling CRSP?

In the latest 13F filing (Q3 2026), Encore Global Management, LP held unchanged its position in CRSP. The position peaked in Q3 2026 at 30.56K shares.

Which other funds hold CRSP?

Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.